[at noodls] – NEW YORK–(BUSINESS WIRE)–A new survey shows that when it comes to getting screened for skin cancer, one in six men avoid going for fear of the results they will receive.This may be one reason why men … moreView todays social media effects on BMYView the latest stocks trending across Twitter. Click to view dashboardSee who Bristol is […]
[at noodls] – New data on an investigational, all-oral, triple DAA regimen of daclatasvir, asunaprevir and BMS-791325 to be included in official ILC Press Conference on April 24 New ALT flare data further characterize … moreView todays social media effects on BMYView the latest stocks trending across Twitter. Click to view dashboardSee who Bristol is hiring next, click here to […]
[Business Wire] – PRINCETON, N.J. & NEW YORK–(BUSINESSWIRE)– Bristol-Myers Squibb (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) announced today that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved ELIQUIS® … moreView todays social media effects on BMYView the latest stocks trending across Twitter. Click to view dashboardSee who Bristol is hiring next, click here to view […]
[ACN Newswire] – By Ivan DeryuginThe biotechnology sector is one where growth is, for the most part, fueled by a single factor: new drugs. Companies that develop the next generation of drugs for a market stand to gain … moreView todays social media effects on BMYView the latest stocks trending across Twitter. Click to view dashboard […]
[Business Wire] – NEW YORK–(BUSINESSWIRE)– The Bristol-Myers Squibb Foundation today marked World Diabetes Day and the second anniversary of its Together on Diabetesâ„¢ initiative by issuing the initiative’s second annual … moreView todays social media effects on BMYView the latest stocks trending across Twitter. Click to view dashboard […]
[ACN Newswire] – By Jake KingWith Gilead’s (NASDAQ:GILD) reported 100% Hepatitis C virologic response rate over the weekend, rivals Achillion (NASDAQ:ACHN) and Vertex (NASDAQ:VRTX) traded down 15% and 5% respectively at … moreView todays social media effects on BMYView the latest stocks trending across Twitter. Click to view dashboard […]
[Business Wire] – NEW YORK–(BUSINESSWIRE)– The Bristol-Myers Squibb Foundation and its partners today launched a Centers of Excellence Conference for Community Based Viral Hepatitis Interventions to share best practices … moreView todays social media effects on BMYView the latest stocks trending across Twitter. Click to view dashboard […]
[ACN Newswire] – By David SobekIn November of 2011, Gilead (NASDAQ:GILD) announced that it reached an agreement to purchase Pharmasset for $11 billion, an 89% premium to its previous close. CEO John Martin noted , the … moreView todays social media effects on BMYView the latest stocks trending across Twitter. Click to view dashboard […]
[ACN Newswire] – By Jake KingChalk another nuc up to the FDA’s growing list of safety-related development interruptions. On Tuesday, BioCryst Pharmaceuticals (NASDAQ:BCRX) announced that it has withdrawn an … moreView todays social media effects on BMYView the latest stocks trending across Twitter. Click to view dashboard […]
[ACN Newswire] – By Jake KingDevelopers of potential Hepatitis C (HCV) treatments are among the most-traded in the healthcare industry on Monday, following an announcement from Abbot Laboratories (NYSE:ABT) that a combinations … moreView todays social media effects on BMYView the latest stocks trending across Twitter. Click to view dashboard […]
